MSD is a global health care leader working to address unmet health needs. It provides innovative medicines, vaccines, biologic therapies and animal health products to help improve health and well-being. MSD works with customers in 140 countries to deliver broad-based health care solutions. The company is known as Merck in the United States and Canada. Everywhere else, they are known as MSD.
Morocco acts as the regional hub for MSD, the head office for Tunisia, Morocco and the 27 countries of the French West Africa Region.
With a steady focus on innovation and sound science, MSD works to deliver vaccines, medications and animal health products that can help millions of people.
Their mission is to provide superior medicines which enhance patients’ quality of life. MSD employ the best people, use exceptional ideas and breakthrough research to make world-leading products.
Contact Details
MSD Maroc SA
166 Bd Zerktouni
Casablanca, Morocco
www.merck.com
Alain Barry, managing director of MSD in Morocco, shares how the organization is partnering with the Moroccan healthcare community to ensure that patients have access to innovative therapies and vaccines.…
Looking back on 11 years of business experience in Morocco, Jean-Charles Damblin of the country’s French Chamber of Commerce and Industry (CCI) is more optimistic than ever about the business…
Women’s health specialist Versalya enjoyed a resurgent 2022 in Morocco under the leadership of Sofia Lahlou. She explains some of the key trends in the Moroccan women’s health space, how…
As North Africa cluster lead Pfizer veteran Diego Forero heads up Morocco, Tunisia, Libya, and Algeria in addition to being the country manager for Morocco. He describes the company’s 57-year…
CEO Mia Lahlou-Filali walks us through Pharma 5’s commitment to “Made in Morocco” generics, an approach that has led the company to represent one third of the country’s generics market.…
Driss Chaoui outlines recent milestones in Afric-Phar’s over 50-year history, including the launch of its first in-house developed generic, and discusses the firm’s unique focus on orphan and rare diseases…
Three years on from his last PharmaBoardroom interview, Karim Lahlou highlights the evolution of Moroccan pharma manufacturer Iberma as it expands its activities from solely in-licensing to developing and selling…
Merck Morocco’s Ahmad ALMWAKEH feels that the winds of change are blowing in the right direction across Moroccan healthcare, with a well-defined national strategy in place to expand coverage to…
Camilia Benani, recently promoted to partner at DLA Piper’s Casablanca office, explains why the Moroccan healthcare sector has become a lightning rod for M&A activity in recent years. Drawing on…
DHL’s Tina Manoukian lays out how the global logistics giant helped ensure the safe and timely distribution of medicines and vaccines during the COVID-19 pandemic, outlines the scope and scale…
Wafaa Farhat Agoumi serves as DG of the Health Engineering and Project Management Graduate School (ESISMP) in Casablanca, Morocco, as well as president of the African Association for Clinical Research…
With a generational universal healthcare reform underway in Morocco, the country’s Minister of Health and Social Protection Khalid Aït Taleb outlines why the ongoing updates to his country’s healthcare system…
Recently rebranded from its former name, AMIP, the Moroccan Federation of Pharmaceutical Industry and Innovation (FMIIP) represents the local manufacturers operating in Morocco, which hold a domestic market share of…
See our Cookie Privacy Policy Here
